
Robert S. Landsman
Examiner (ID: 14280, Phone: (571)272-0888 , Office: P/1647 )
| Most Active Art Unit | 1647 |
| Art Unit(s) | 1647, 1646 |
| Total Applications | 2029 |
| Issued Applications | 1242 |
| Pending Applications | 272 |
| Abandoned Applications | 566 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5569775
[patent_doc_number] => 20090253153
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-08
[patent_title] => 'METHODS OF USING A G PROTEIN-COUPLED RECEPTOR TO IDENTIFY PEPTIDE YY (PYY) SECRETAGOGUES AND COMPOUNDS USEFUL IN THE TREATMENT OF CONDITIONS MODULATED BY PYY'
[patent_app_type] => utility
[patent_app_number] => 12/391097
[patent_app_country] => US
[patent_app_date] => 2009-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 63094
[patent_no_of_claims] => 109
[patent_no_of_ind_claims] => 19
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0253/20090253153.pdf
[firstpage_image] =>[orig_patent_app_number] => 12391097
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/391097 | Methods of using GPR119 to identify peptide YY (PYY) secretagogues and compounds useful in the treatment of conditions modulated by PYY | Feb 22, 2009 | Issued |
Array
(
[id] => 5368477
[patent_doc_number] => 20090306036
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-10
[patent_title] => 'METHODS OF SCREENING AGENTS, CONJUGATES OR CONJUGATE MOIETIES FOR TRANSPORT BY A PEPT2 TRANSPORTER'
[patent_app_type] => utility
[patent_app_number] => 12/390327
[patent_app_country] => US
[patent_app_date] => 2009-02-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 11047
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0306/20090306036.pdf
[firstpage_image] =>[orig_patent_app_number] => 12390327
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/390327 | Methods of treating using conjugates transported by a PEPT2 transporter | Feb 19, 2009 | Issued |
Array
(
[id] => 4572479
[patent_doc_number] => 07829536
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-11-09
[patent_title] => 'Method of treating lymphedema comprising administering VEGF-D'
[patent_app_type] => utility
[patent_app_number] => 12/366359
[patent_app_country] => US
[patent_app_date] => 2009-02-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 11
[patent_no_of_words] => 18462
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/829/07829536.pdf
[firstpage_image] =>[orig_patent_app_number] => 12366359
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/366359 | Method of treating lymphedema comprising administering VEGF-D | Feb 4, 2009 | Issued |
Array
(
[id] => 8127523
[patent_doc_number] => 20120088311
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-04-12
[patent_title] => 'Immuno-Detection of a Cancerous State in a Subject'
[patent_app_type] => utility
[patent_app_number] => 12/866683
[patent_app_country] => US
[patent_app_date] => 2009-02-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 9033
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0088/20120088311.pdf
[firstpage_image] =>[orig_patent_app_number] => 12866683
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/866683 | Immuno-Detection of a Cancerous State in a Subject | Feb 4, 2009 | Abandoned |
Array
(
[id] => 5564746
[patent_doc_number] => 20090137599
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-05-28
[patent_title] => 'Methods of identifying responders to dopamine agonist therapy'
[patent_app_type] => utility
[patent_app_number] => 12/322319
[patent_app_country] => US
[patent_app_date] => 2009-01-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2801
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0137/20090137599.pdf
[firstpage_image] =>[orig_patent_app_number] => 12322319
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/322319 | Methods of identifying responders to dopamine agonist therapy | Jan 29, 2009 | Issued |
Array
(
[id] => 6622718
[patent_doc_number] => 20100003703
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-01-07
[patent_title] => 'ASSAY SYSTEM FOR GLP-2 RECEPTOR LIGANDS'
[patent_app_type] => utility
[patent_app_number] => 12/358123
[patent_app_country] => US
[patent_app_date] => 2009-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 3559
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0003/20100003703.pdf
[firstpage_image] =>[orig_patent_app_number] => 12358123
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/358123 | Ex vivo method for determining potential GLP-2 receptor modulators | Jan 21, 2009 | Issued |
Array
(
[id] => 8458039
[patent_doc_number] => 08293706
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-10-23
[patent_title] => 'Method for inhibiting release of hepatitis B virus from liver cells'
[patent_app_type] => utility
[patent_app_number] => 12/811912
[patent_app_country] => US
[patent_app_date] => 2009-01-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4078
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12811912
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/811912 | Method for inhibiting release of hepatitis B virus from liver cells | Jan 6, 2009 | Issued |
Array
(
[id] => 7686140
[patent_doc_number] => 20090178151
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-07-09
[patent_title] => 'NUCLEIC ACID ENCODING A NOVEL PROSTAGLANDIN RECEPTOR PROTEIN AND METHODS OF USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/348990
[patent_app_country] => US
[patent_app_date] => 2009-01-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 29091
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0178/20090178151.pdf
[firstpage_image] =>[orig_patent_app_number] => 12348990
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/348990 | Nucleic acid molecules encoding prostaglandin receptor proteins | Jan 5, 2009 | Issued |
Array
(
[id] => 9046445
[patent_doc_number] => 08540998
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-09-24
[patent_title] => 'Methods for treating cancer using ephrin type-A receptor 10 antibodies conjugated to cytotoxic agents'
[patent_app_type] => utility
[patent_app_number] => 12/810095
[patent_app_country] => US
[patent_app_date] => 2008-12-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 2
[patent_no_of_words] => 44567
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12810095
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/810095 | Methods for treating cancer using ephrin type-A receptor 10 antibodies conjugated to cytotoxic agents | Dec 23, 2008 | Issued |
Array
(
[id] => 7509977
[patent_doc_number] => 20110256143
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-10-20
[patent_title] => 'FDF03 Antibodies and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 12/809554
[patent_app_country] => US
[patent_app_date] => 2008-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 10310
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0256/20110256143.pdf
[firstpage_image] =>[orig_patent_app_number] => 12809554
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/809554 | Methods for inhibiting tumor growth or reducing metastatic burden in a subject by administering FDF03 antibodies | Dec 17, 2008 | Issued |
Array
(
[id] => 6196626
[patent_doc_number] => 20110028384
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-02-03
[patent_title] => 'RAP VARIANTS FOR DRUG DELIVERY'
[patent_app_type] => utility
[patent_app_number] => 12/747354
[patent_app_country] => US
[patent_app_date] => 2008-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 18829
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0028/20110028384.pdf
[firstpage_image] =>[orig_patent_app_number] => 12747354
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/747354 | RAP variants for drug delivery and methods of use thereof | Dec 9, 2008 | Issued |
Array
(
[id] => 5386527
[patent_doc_number] => 20090227772
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-09-10
[patent_title] => 'Human GIL-19/AE289 proteins and polynucleotides encoding same'
[patent_app_type] => utility
[patent_app_number] => 12/292965
[patent_app_country] => US
[patent_app_date] => 2008-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 18593
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0227/20090227772.pdf
[firstpage_image] =>[orig_patent_app_number] => 12292965
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/292965 | Human GIL-19/AE289 proteins | Nov 30, 2008 | Issued |
Array
(
[id] => 5574962
[patent_doc_number] => 20090142323
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-06-04
[patent_title] => 'METHODS FOR TREATING A DISORDER BY REGULATING GPRC6A'
[patent_app_type] => utility
[patent_app_number] => 12/324406
[patent_app_country] => US
[patent_app_date] => 2008-11-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 12313
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0142/20090142323.pdf
[firstpage_image] =>[orig_patent_app_number] => 12324406
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/324406 | METHODS FOR TREATING A DISORDER BY REGULATING GPRC6A | Nov 25, 2008 | Abandoned |
Array
(
[id] => 6258409
[patent_doc_number] => 20100029902
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-02-04
[patent_title] => 'COATED NANOPARTICLES AND METHOD FOR COATING NANOPARTICLES'
[patent_app_type] => utility
[patent_app_number] => 12/324821
[patent_app_country] => US
[patent_app_date] => 2008-11-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 3340
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0029/20100029902.pdf
[firstpage_image] =>[orig_patent_app_number] => 12324821
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/324821 | COATED NANOPARTICLES AND METHOD FOR COATING NANOPARTICLES | Nov 25, 2008 | Abandoned |
Array
(
[id] => 5479517
[patent_doc_number] => 20090202474
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-13
[patent_title] => 'EXPRESSION OF ORPHAN GPR64 IN INFLAMMATORY DISEASES'
[patent_app_type] => utility
[patent_app_number] => 12/273945
[patent_app_country] => US
[patent_app_date] => 2008-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 128
[patent_figures_cnt] => 128
[patent_no_of_words] => 34134
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12273945
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/273945 | EXPRESSION OF ORPHAN GPR64 IN INFLAMMATORY DISEASES | Nov 18, 2008 | Abandoned |
Array
(
[id] => 7515518
[patent_doc_number] => 08039590
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-10-18
[patent_title] => 'Heteromeric taste receptors comprising T1R2/T1R3 domains'
[patent_app_type] => utility
[patent_app_number] => 12/270857
[patent_app_country] => US
[patent_app_date] => 2008-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 23
[patent_no_of_words] => 30213
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 107
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/039/08039590.pdf
[firstpage_image] =>[orig_patent_app_number] => 12270857
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/270857 | Heteromeric taste receptors comprising T1R2/T1R3 domains | Nov 13, 2008 | Issued |
Array
(
[id] => 7724156
[patent_doc_number] => 08097426
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-01-17
[patent_title] => 'Methods of screening T1R2/T1R3 receptors for compounds which modulate sweet taste signaling'
[patent_app_type] => utility
[patent_app_number] => 12/270855
[patent_app_country] => US
[patent_app_date] => 2008-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 23
[patent_no_of_words] => 30172
[patent_no_of_claims] => 134
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 262
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/097/08097426.pdf
[firstpage_image] =>[orig_patent_app_number] => 12270855
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/270855 | Methods of screening T1R2/T1R3 receptors for compounds which modulate sweet taste signaling | Nov 13, 2008 | Issued |
Array
(
[id] => 5539262
[patent_doc_number] => 20090221067
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-09-03
[patent_title] => 'Cell lines that express hetero oligomeric taste receptors'
[patent_app_type] => utility
[patent_app_number] => 12/270824
[patent_app_country] => US
[patent_app_date] => 2008-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 30183
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0221/20090221067.pdf
[firstpage_image] =>[orig_patent_app_number] => 12270824
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/270824 | Cell lines that express hetero oligomeric taste receptors | Nov 12, 2008 | Issued |
Array
(
[id] => 5539197
[patent_doc_number] => 20090221002
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-09-03
[patent_title] => 'Methods of quantifying taste of compounds for food or beverages'
[patent_app_type] => utility
[patent_app_number] => 12/270841
[patent_app_country] => US
[patent_app_date] => 2008-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 30151
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0221/20090221002.pdf
[firstpage_image] =>[orig_patent_app_number] => 12270841
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/270841 | Methods of quantifying taste of compounds for food or beverages | Nov 12, 2008 | Issued |
Array
(
[id] => 5539196
[patent_doc_number] => 20090221001
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-09-03
[patent_title] => 'Methods for identifying compounds that modulate the T1R1/T1R3 umami taste receptor'
[patent_app_type] => utility
[patent_app_number] => 12/270838
[patent_app_country] => US
[patent_app_date] => 2008-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 30159
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0221/20090221001.pdf
[firstpage_image] =>[orig_patent_app_number] => 12270838
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/270838 | Methods for identifying compounds that modulate T1R1/T1R3 umami taste receptors | Nov 12, 2008 | Issued |